EZZ Life Science Holdings Limited (ASX:EZZ)

Market Cap	72.65M
Revenue (ttm)	75.03M
Net Income (ttm)	9.02M
Shares Out	47.17M
EPS (ttm)	0.20
PE Ratio	7.58
Forward PE	8.70
Dividend	0.04 (2.74%)
Ex-Dividend Date	May 16, 2025

Volume	14,488
Average Volume	37,967
Open	1.565
Previous Close	1.540
Day's Range	1.540 - 1.570
52-Week Range	0.820 - 4.970
Beta	0.37
RSI	52.52
Earnings Date	May 26, 2025

About EZZ Life Science Holdings

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally. The company operates through Brought in Lines and Company Owned Products segments. It is also involved in the wholesale distribution of the EAORON branded skin care products to retailers. In addition, the company engages in research, development, and sale of genomics. Further, it offers precision nutrition research products under the EZZ brand. EZZ Life Sci...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EZZ

Financial Performance

In 2024, EZZ Life Science Holdings's revenue was 66.44 million, an increase of 78.88% compared to the previous year's 37.14 million. Earnings were 6.96 million, an increase of 91.87%.